Halozyme Confirms $5 Million Milestone Payment From AbbVie By: Benzinga via Benzinga January 21, 2016 at 14:54 PM EST Shares of Halozyme Therapeutics, Inc. (NASDAQ: HALO) were trading higher by 0.62 percent during Thursday's ... Read More >> Related Stocks: AbbVie Halozyme Therapeutic